Investor Relations
TFF Pharmaceuticals, Inc. is an early-stage biopharmaceutical company focused on the development and commercialization of new inhalation products for the treatment of chronic respiratory diseases and lung conditions.
In early testing the Thin Film Freezing (TFF) proprietary platform significantly improved the solubility of drugs that have poor water solubility.
DIRECTOR INTERVIEWS- Proactive Investors, with Christine Corrado
At Biotech Showcase, Jan. 15, 2020
INNOVATORS with Jane King – interviewing CEO Glenn Mattes
& Dr. Bill Williams - Professor at Univ. of Texas – Austin
At the NASDAQ Market Site, Nov. 20, 2019
Press Releases
Featured Presentation
